Puma Biotechnology
PBYI
PBYI
102 hedge funds and large institutions have $92.2M invested in Puma Biotechnology in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
39% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 33
59% less capital invested
Capital invested by funds: $226M → $92.2M (-$134M)
Holders
102
Holding in Top 10
–
Calls
$725K
Puts
$519K
Top Buyers
| 1 | +$4.48M | |
| 2 | +$2.19M | |
| 3 | +$2.08M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.36M |
| 5 |
Walleye Capital
New York
|
+$1.23M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$9.77M | |
| 3 | -$9.11M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$6.06M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$4.18M |